P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 26 June 2019 | 12:19 pm

Press Release Archives

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure - Fast Track designation facilitates development of new therapies that treat more ...

Published 26 June 2019 | 7:25 am

Novartis highlights new publication showing IL-17A antibody Cosentyx® improves inflammation and rapidly suppresses IL-23 in plaque psoriasis

New data show that Cosentyx modulates gene expression leading to substantial improvement of inflammation, as early as Week 12 by reversing plaque histopathology in the more ...

Published 26 June 2019 | 4:05 am

Takeda Selects Five New Partnerships for Annual Global Corporate Social Responsibility (CSR) Program, Supporting Disease Prevention to Improve Health in Developing and Emerging Countries

- Takeda's founding mission to serve patients, wherever they are, drives its increased commitments to disease prevention, capacity building, and access to healthcare in more ...

Published 25 June 2019 | 11:58 pm

What Are Electrolytes?

Sodium, potassium and other electrolytes can optimize your hydration plan for healthier, stronger running performances. more ...

Published 25 June 2019 | 2:55 pm

Flexibility at Novartis: Christine Sturchler and Aileen Wrynn

Sturchler and Wrynn explain why their job-sharing experience was one of the most successful and energizing periods of their careers. more ...

Published 25 June 2019 | 2:35 pm

Takeda Announces Baxalta's Commencement of Consent Solicitation with Respect to Baxalta's 3.600% Senior Notes due 2022, 4.000% Senior Notes due 2025, 5.250% Senior Notes due 2045

Osaka, Japan, June 25, 2019, --- Takeda Pharmaceutical Company Limited, (" Takeda ") ( TSE:4502/NYSE:TAK ) today announced that more ...

Published 25 June 2019 | 10:43 am

Fixing the weak links

Chinks in the supply chain resulted in cost mark-ups putting modern cancer therapies out of reach for patients in sub-Saharan Africa. more ...

Published 25 June 2019 | 1:14 am

FOSTER CITY, Calif. & KOBE, Japan --(BUSINESS WIRE)--Jun. 24, 2019--

Gilead Sciences, Inc. (NASDAQ: GILD) and Carna Biosciences Inc. (JASDAQ: 4572) today announced that the companies have entered into a research and development more ...

Published 24 June 2019 | 11:41 pm

Novo Nordisk A/S - Share repurchase programme

Bagsværd, Denmark, 24 June 2019 - On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the more ...

Published 24 June 2019 | 10:36 pm

Novartis provides update on phase 2b ENCORE-LF trial in NASH cirrhosis

Conatus today announced top-line results from the ENCORE-LF trial, which did not meet its primary endpoint more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
61st P-D-R Annual General Meeting, Summit, NJ, USA, September 17 - 20 2019

61st P-D-R Annual General Meeting, Summit, NJ, USA, September 17 - 20 2019